Growth in occupied warehouse space in MetroWest grew by 4 percent in the third quarter, leading the entire Greater Boston market, according to a new report Monday by Transwestern Consulting Group.
After being delisted on NASDAQ last week, Holliston biotech Biostage has laid off 17 of its 24 employees, a 71-percent reduction, the company announced Thursday.
Biostage, Inc. of Holliston has enough funding to get it through the end of 2018, following a stock purchase worth $3.1 million by one of its investors.